Torsades de pointes

被引:17
作者
Sami Viskin
机构
[1] Sourasky-Tel Aviv Medical Center and Sackler School of Medicine,Department of Cardiology
[2] Tel Aviv University,undefined
关键词
Isoproterenol; Main Side Effect; Magnesium Sulfate; Main Drug Interaction; Fexofenadine;
D O I
10.1007/s11936-999-0022-8
中图分类号
学科分类号
摘要
The treatment of torsades de pointes is very effective but also very specific. Prompt recognition of torsades de pointes is imperative, and the clue to its recognition is increased awareness. The QT interval in the long QT syndrome (LQTS) is not only prolonged but also odd looking. This abnormal QT morphology, which has been well described for the congenital LQTS, is also observable in the acquired LQTS. Moreover, the onset of ventricular extrasystoles and the appearance of bizarre QT changes (with gian U waves) in the sinus complex that follows each postextrasystolic pause are signs of "impending torsades." Emergency treatment includes 1) withdrawal of any precipitating agents; 2) intravenous administration of magnesium sulfate, potassium supplements, and lidocaine; and 3) adequate sedation. For drug-refractory torsades de pointes, transvenous ventricular pacing at rapid rates will shorten the QT interval, eliminate the pauses that precipitate torsades, and prevent further bursts of arrhythmias. Acceleration of the basic heart rate with isoproterenol is also effective in preventing immediate recurrence. Isoproterenol should only be used, however, when 1) torsades de pointes is due to an acquired LQTS; 2) the underlying rhythm is slow, and torsades is clearly "pause dependent"; and 3) transvenous pacing cannot be immediately implemented.
引用
收藏
页码:187 / 195
页数:8
相关论文
共 98 条
[1]  
Roden D(1997)Recent advances in the long QT syndrome Cardiac Electrophysiol Rev 1 262-263
[2]  
Roden D(1996)Multiple mechanisms in the long QT syndrome. Current knowledge, gaps, and future directions Circulation 94 1996-2012
[3]  
Lazzara R(1995)Electrophysiologic mechanisms of the long QT interval syndromes and torsades de pointes Ann Intern Med 122 701-714
[4]  
Rosen M(1988)The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis Prog Cardiovasc Dis 31 115-172
[5]  
Tan HL(1997)Molecular biology of the long QT syndrome: impact on management Pacing Clin Electrophysiol 20 II2052-II2057
[6]  
Hou CJ(1996)Extracellular potassium modulation of drug block of IKr: implications for torsades de pointes and reverse use-dependence Circulation 93 407-411
[7]  
Lauer MR(1996)Cellular and ionic mechanisms underlying erythromycin-induce long QT intervals and torsades de pointes J Am Coll Cardiol 28 1836-1848
[8]  
Sung RJ(1996)Torsades de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole J Am Coll Cardiol 28 1556-1561
[9]  
Jackman WM(1994)Ketanserin inhibits depolarization-activated outward potassium current in rat ventricular myocytes Circ Res 75 711-721
[10]  
Friday KJ(1998)Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval Circulation 97 204-210